Clinical Trial

Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk

Study acronym: EPICODE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 12, 2021 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2014-07-16; most recent amendment 2021-01-08.
Status change: Not Yet Recruiting → Recruiting 2014-09-23
Trial Details
NCT Number NCT02193464
Lead Sponsor Kyungpook National University Hospital
Collaborators: Yeungnam University Hospital, Daegu Catholic University Medical Center, DongGuk University
Conditions Idiopathic Chronic Inflammatory Bowel Disease
Enrollment 100 participants
Start Date 2014-09
Primary Completion 2025-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2021-01-12